Related Experiment Video
Updated: Jul 11, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Cardiac Involvement Due to COVID-19: Insights from Imaging and Histopathology
Valentina O Puntmann1, Anastasia Shchendrygina1, Carlos Rodriguez Bolanos1
1Institute for Experimental and Translational Cardiovascular Imaging, DZHK Centre for Cardiovascular Imaging, Goethe University Frankfurt Frankfurt am Main, Germany.
Insights
Post-acute cardiovascular sequelae of COVID-19 (PASC) cause lingering heart problems, affecting both those with prior heart conditions and previously healthy individuals. Recognizing and diagnosing these complex cardiovascular syndromes is crucial for patient outcomes.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to persistent cardiac symptoms, termed post-acute cardiovascular sequelae (PASC).
- Acute cardiac injury in COVID-19 is linked to cytokine release, ischemia, and thrombosis, particularly impacting patients with pre-existing heart disease.
- Myocarditis from direct viral infection is uncommon; chronic PASC involves either exacerbation of existing cardiovascular disease or a distinct inflammatory syndrome.
Purpose of the Study:
- To highlight the growing recognition of post-acute cardiovascular sequelae (PASC) following SARS-CoV-2 infection.
- To differentiate between PASC presentations: worsening of pre-existing cardiovascular disease versus a new cardiovascular syndrome driven by immune dysregulation.
- To underscore the challenges in clinical recognition and management of PASC and the need for improved diagnostic tools.
Main Methods:
- Review of current understanding of cardiac complications following SARS-CoV-2 infection.
- Analysis of the mechanisms driving acute cardiac injury and chronic PASC presentations.
- Discussion of clinical implications, diagnostic needs, and management challenges for PASC.
Main Results:
- PASC encompasses two main phenotypes: exacerbation of pre-existing cardiovascular disease and a novel cardiovascular syndrome linked to immune dysregulation.
- Both PASC presentations are associated with elevated cardiovascular risk, long-term disability, and diminished quality of life.
- The latter PASC phenotype affects a significant number of individuals who were previously in good health.
Conclusions:
- Effective clinical recognition and management of PASC remain significant challenges.
- There is a critical need for sensitive diagnostic methods to identify subtle inflammatory changes in PASC-cardiovascular syndrome.
- Enhanced clinical expertise in managing inflammatory cardiac conditions is essential for addressing PASC.
Abstract:
Lingering cardiac symptoms are increasingly recognised complications of severe acute respiratory syndrome coronavirus 2 infection, now referred to as post-acute cardiovascular sequelae of COVID-19 (PASC). In the acute phase, cardiac injury is driven by cytokine release and stems from ischaemic and thrombotic complications, resulting in myocardial necrosis. Patients with pre-existing cardiac conditions are particularly vulnerable. Myocarditis due to a direct viral infection is rare. Chronic symptoms relate to either worsening of pre-existing heart disease (PASC - cardiovascular disease) or delayed chronic inflammatory condition due to heterogenous immune dysregulation (PASC - cardiovascular syndrome), the latter affecting a broad segment of previously well people. Both PASC presentations are associated with increased cardiovascular risk, long-term disability and reduced quality of life. The recognition and management of PASC in clinical settings remains a considerable challenge. Sensitive diagnostic methods are needed to detect subtler inflammatory changes that underlie the persistent symptoms in PASC - cardiovascular syndrome, alongside considerable clinical experience in inflammatory cardiac conditions.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Imaging Studies for Cardiovascular System V: CT
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests

